Brief: Venus Remedies Receives Final 110 Mln Rupees Payment From Cipla
Dec 8 (Reuters) - VENUS REMEDIES VENR.NS VENUS REMEDIES - RECEIVES FINAL 110 MILLION RUPEES PAYMENT FROM CIPLA Source text: ID:nNSE2LMwFT Further company coverage: VENR.NS (Reporting by Abhirami G from Bengaluru) ((abhirami.g@thomsonreuters.com;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate